Alexandra L Quittner1, Janice Abbott2, Saida Hussain1, Thida Ong3, Ahmet Uluer4, Sarah Hempstead5, Paula Lomas5, Beth Smith6. 1. Research Institute, Nicklaus Children's Research Institute, Miami, Florida. 2. School Psychology, University of Lancashire, Preston, UK. 3. Pediatric Pulmonology, Seattle Children's Hospital, University of Washington, Seattle, Washington. 4. Division of Pulmonary Medicine, Boston Children's Hospital, Harvard University, Boston, Massachusetts. 5. Clinical Affairs, Cystic Fibrosis Foundation, Bethesda, Maryland. 6. Department of Psychiatry, State University of New York, Buffalo, New York.
Abstract
BACKGROUND: A large-scale epidemiological study of 6088 individuals with cystic fibrosis (CF) and 4102 caregivers in nine countries documented elevated symptoms of depression and anxiety, leading to international guidelines for annual screening and follow-up. To facilitate national implementation, 84 CF programs funded a mental health coordinators (MHC). Implementation was evaluated after 1 year using the consolidated framework for implementation research (CFIR) to identify facilitators and barriers. METHODS: A 45-item internet survey was developed to assess relevant CFIR implementation steps. Surveys were completed in 2016. It assessed five domains tailored to study aims: (a) Intervention characteristics, (b) outer setting, (c) inner setting, (d) characteristics of individuals, and (e) process of implementation. RESULTS: Response rate was 88%, with pediatric and adult programs equally represented. A majority of MHCs were social workers (54.1%) and psychologists (41.9%); 41% had joined the team in the past year. Facilitators across the five domains included universal uptake of screening tools, greater awareness and detection of psychological symptoms, reduced stigma, and positive feedback from patients and families. Barriers included limited staff time, space, and logistics. DISCUSSION: This is the largest systematic effort to integrate mental health screening and treatment into the care of individuals with a serious, chronic illness and their caregivers. MHCs implementing screening, interpretation and follow-up reported positive results, and significant barriers. This national implementation effort demonstrated that depression and anxiety can be efficiently evaluated and treated in a complex, chronic disease. Future efforts include recommending the addition of screening scores to national CF Registries and examining their effects on health outcomes.
BACKGROUND: A large-scale epidemiological study of 6088 individuals with cystic fibrosis (CF) and 4102 caregivers in nine countries documented elevated symptoms of depression and anxiety, leading to international guidelines for annual screening and follow-up. To facilitate national implementation, 84 CF programs funded a mental health coordinators (MHC). Implementation was evaluated after 1 year using the consolidated framework for implementation research (CFIR) to identify facilitators and barriers. METHODS: A 45-item internet survey was developed to assess relevant CFIR implementation steps. Surveys were completed in 2016. It assessed five domains tailored to study aims: (a) Intervention characteristics, (b) outer setting, (c) inner setting, (d) characteristics of individuals, and (e) process of implementation. RESULTS: Response rate was 88%, with pediatric and adult programs equally represented. A majority of MHCs were social workers (54.1%) and psychologists (41.9%); 41% had joined the team in the past year. Facilitators across the five domains included universal uptake of screening tools, greater awareness and detection of psychological symptoms, reduced stigma, and positive feedback from patients and families. Barriers included limited staff time, space, and logistics. DISCUSSION: This is the largest systematic effort to integrate mental health screening and treatment into the care of individuals with a serious, chronic illness and their caregivers. MHCs implementing screening, interpretation and follow-up reported positive results, and significant barriers. This national implementation effort demonstrated that depression and anxiety can be efficiently evaluated and treated in a complex, chronic disease. Future efforts include recommending the addition of screening scores to national CF Registries and examining their effects on health outcomes.
Authors: Tammy K Stump; Kristen Ethier; Lisa R Hirschhorn; Andrea Dakin; Nora Bouacha; Angela Freeman; Jacqueline Bannon; Walter Gómez; Judith T Moskowitz; Alida Bouris Journal: J Acquir Immune Defic Syndr Date: 2022-07-01 Impact factor: 3.771
Authors: Traci M Kazmerski; Natalie E West; Raksha Jain; Ahmet Uluer; Anna M Georgiopoulos; Moira L Aitken; Jennifer L Taylor-Cousar Journal: Pediatr Pulmonol Date: 2021-08-18
Authors: Beth A Smith; Anna M Georgiopoulos; Amy Mueller; Janice Abbott; Paula Lomas; Enid Aliaj; Alexandra L Quittner Journal: J Cyst Fibros Date: 2021-12 Impact factor: 5.482
Authors: Aricca D Van Citters; Olivia Dieni; Peter Scalia; Christopher Dowd; Kathryn A Sabadosa; Jill D Fliege; Manu Jain; Robert W Miller; Clement L Ren Journal: J Cyst Fibros Date: 2021-12 Impact factor: 5.482